facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
6/2023
vol. 110
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Opis przypadku

Diagnostic and therapeutic challenges in erythema elevatum diutinum

Justyna Milewska
1
,
Paulina Chmielińska
1
,
Joanna Czuwara
1
,
Alicja Kryst
1
,
Magdalena Jasińska
1
,
Adriana Rakowska
1
,
Małgorzata Olszewska
1
,
Lidia Rudnicka
1

  1. Department of Dermatology, Medical University of Warsaw, Warsaw, Poland
Dermatol Rev/Przegl Dermatol 2023, 110, 711-715
Data publikacji online: 2024/05/03
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction:
Erythema elevatum diutinum (EED) is a rare form of cutaneous fibrosing type of leukocytoclastic vasculitis leading sometimes to nodule formation, imitating neoplastic process.

Case report:
We present the case of a 65-year-old woman with a 6-year history of cutaneous presentation of erythema elevatum diutinum, coexisting with myasthenia gravis and monoclonal IgA gammopathy. Dermoscopy of the skin lesions showed prominent thick arborizing vessels in a concentric alignment. Previous treatment with the use of methotrexate, dapsone, mycophenolate mofetil and cyclosporine did not stop the disease progression. Laboratory tests showed the presence of monoclonal protein IgAk in the serum and X-ray examination showed numerous fine-spot thinning of bone structure, especially within the skull bones. Hematological treatment with thalidomide and cyclophosphamide was introduced. A rapid resolution of skin lesions was observed.

Conclusions:
This case shows that management of the underlying hematological abnormality may be essential for successful therapy of the otherwise treatment resistant erythema elevatum diutinum.



© 2024 Termedia Sp. z o.o.
Developed by Bentus.